Aerophobin-1 from the Marine Sponge Aplysina aerophoba Modulates Osteogenesis in Zebrafish Larvae.

Abstract

Longer life expectancy has led to an increase in efforts directed to the discovery of new healing agents for disorders related to aging, such as bone diseases. Harboring an incredible variety of bioactive metabolites, marine organisms are standing out as fruitful sources also in this therapeutic field. On the other hand, the in vivo zebrafish model has proven to be an excellent low-cost screening platform for the fast identification of molecules able to regulate bone development. By using zebrafish larvae as a mineralization model, we have thus evaluated the effects of the crude acetonic extract from the marine sponge Aplysina aerophoba and its bromotyrosine components on bone development. Obtained results led to the selection of aerophobin-1 (1) as a promising candidate for applications in regenerative medicine, paving the way for the development of a novel therapeutic option in osteoporosis treatment.

• Authors: Marta Carnovali, Maria Letizia Ciavatta, Ernesto Mollo, Vassilios Roussis, Giuseppe Banfi, Marianna Carbone, Massimo Mariotti
• Journal: Marine drugs (Mar Drugs) Vol. 20 Issue 2 (Feb 11 2022) ISSN: 1660-3397 [Electronic] Switzerland
• PMID: 35200664 (Publication Type: Journal Article)

Chemical References

• Biological Products

Topics

• Animals
• Biological Products (isolation & purification, pharmacology)
• Bone Development (drug effects)
• Larva (drug effects)
• Osteogenesis (drug effects)
• Porifera (metabolism)
• Zebrafish